Fradafiban (BIBU-52) |
Katalog-Nr.GC32562 |
Fradafiban (BIBU-52) ist ein nichtpeptidischer Thrombozyten-Glykoprotein-IIb/IIIa-Antagonist, der mit einem Kd-Wert von 148 nM an den humanen Thrombozyten-GP IIb/IIIa-Komplex bindet.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 148396-36-5
Sample solution is provided at 25 µL, 10mM.
Fradafiban is a nonpeptide platelet glycoprotein IIb/IIIa antagonist, which binds to the human platelet GP IIb/IIIa complex with a Kd value of 148 nM.
Fradafiban is a nonpeptide mimetic of the arginine-glycine-aspartic acid recognition sequence. Fradafiban binds with high affinity and selectivity to the human platelet GP IIb/IIIa complex and potently inhibits human platelet aggregation in vitro. Fradafiban reversibly binds to the human platelet GP IIb/IIIa complex with a Kd value of 148 nM[1].
Fradafiban has only very limited oral activity probably due to its high polarity and thus poor absorption after oral ingestion[1].
[1]. Müller TH, et al. Profound and sustained inhibition of platelet aggregation by Fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, Lefradafiban, in men. Circulation. 1997 Aug 19;96(4):1130-8.
Average Rating: 5
(Based on Reviews and 12 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *